Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Neoplasms × nilotinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Leukemia 13 Gastrointestinal Stromal Tumors 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Chronic-Phase 6 Philadelphia Chromosome 3 Neoplasms 3 Leukemia, Myeloid 3 Hematologic Diseases 3 Bone Marrow Diseases 3 Myeloproliferative Disorders 2 Melanoma 2 Bronchiolitis Obliterans Syndrome 2 Blast Crisis 2 Synovitis, Pigmented Villonodular 1 Recurrence 1 Piebaldism 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neoplastic Processes 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Mastocytosis, Systemic 1 Leukemia, Myeloid, Accelerated Phase 1 Hypereosinophilic Syndrome 1 Hematologic Neoplasms 1 Glioma 1 Giant Cell Tumor of Tendon Sheath 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Leucovorin 4 Irinotecan 4 Fluorouracil 4 Oxaliplatin 3 Bevacizumab 3 cobimetinib 2 Standard of Care 2 Specimen Handling 2 Panitumumab 2 Magnetic Resonance Spectroscopy 2 Ketamine 2 Hydroxychloroquine 2 Cisplatin 2 Capecitabine 2 ulixertinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tivozanib 1 sodium thiosulfate 1 rucaparib 1 romiplostim 1 rilotumumab 1 regorafenib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 osimertinib 1 napabucasin 1 lanreotide 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡